These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16955437)

  • 21. Serotonin and amino acids: partners in delirium pathophysiology?
    van der Mast RC; Fekkes D
    Semin Clin Neuropsychiatry; 2000 Apr; 5(2):125-31. PubMed ID: 10837101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Immunol Lett; 2008 May; 117(2):198-202. PubMed ID: 18367253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.
    Palmer AM; Stratmann GC; Procter AW; Bowen DM
    Ann Neurol; 1988 Jun; 23(6):616-20. PubMed ID: 2457353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Education plays a different role in Frontotemporal Dementia and Alzheimer's disease.
    Borroni B; Alberici A; Agosti C; Premi E; Padovani A
    Int J Geriatr Psychiatry; 2008 Aug; 23(8):796-800. PubMed ID: 18172915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated cerebrospinal fluid tau protein levels in Wernicke's encephalopathy.
    Matsushita S; Miyakawa T; Maesato H; Matsui T; Yokoyama A; Arai H; Higuchi S; Kashima H
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1091-5. PubMed ID: 18445112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma amino acid concentrations in healthy and cognitively impaired oldest-old individuals: associations with anthropometric parameters of body composition and functional disability.
    Ravaglia G; Forti P; Maioli F; Bianchi G; Sacchetti L; Talerico T; Nativio V; Mariani E; Macini P
    Br J Nutr; 2002 Nov; 88(5):563-72. PubMed ID: 12425737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet serotonin and monoamine oxidase in Alzheimer's disease with psychotic features.
    Mimica N; Mück-Seler D; Pivac N; Mustapić M; Dezeljin M; Stipcević T; Presecki P; Radonić E; Folnegović-Smalc V
    Coll Antropol; 2008 Jan; 32 Suppl 1():119-22. PubMed ID: 18405069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease.
    Muck-Seler D; Presecki P; Mimica N; Mustapic M; Pivac N; Babic A; Nedic G; Folnegovic-Smalc V
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1226-31. PubMed ID: 19602426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetyl-L-carnitine in Alzheimer disease: a short-term study on CSF neurotransmitters and neuropeptides.
    Bruno G; Scaccianoce S; Bonamini M; Patacchioli FR; Cesarino F; Grassini P; Sorrentino E; Angelucci L; Lenzi GL
    Alzheimer Dis Assoc Disord; 1995; 9(3):128-31. PubMed ID: 8534410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects.
    Fonteh AN; Harrington RJ; Tsai A; Liao P; Harrington MG
    Amino Acids; 2007 Feb; 32(2):213-24. PubMed ID: 17031479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemorheological mechanisms in Alzheimer's disease.
    Chang CY; Liang HJ; Chow SY; Chen SM; Liu DZ
    Microcirculation; 2007 Aug; 14(6):627-34. PubMed ID: 17710633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease.
    Jiménez-Jiménez FJ; Molina JA; Gómez P; Vargas C; de Bustos F; Benito-León J; Tallón-Barranco A; Ortí-Pareja M; Gasalla T; Arenas J
    J Neural Transm (Vienna); 1998; 105(2-3):269-77. PubMed ID: 9660105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
    Lee JW; Namkoong H; Kim HK; Kim S; Hwang DW; Na HR; Ha SA; Kim JR; Kim JW
    BMC Neurol; 2007 Jun; 7():14. PubMed ID: 17565664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical heterogeneity of Alzheimer's disease according to the age of onset].
    Vilalta-Franch J; Lopez-Pousa S; Garre-Olmo J; Turon-Estrada A; Pericot-Nierga I
    Rev Neurol; 2007 Jul 16-31; 45(2):67-72. PubMed ID: 17642044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
    Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delirium among elderly general medical patients in a New Zealand hospital.
    Holden J; Jayathissa S; Young G
    Intern Med J; 2008 Aug; 38(8):629-34. PubMed ID: 18284464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.